Ron (R.H.) Lin, Ph.D.
Chief Executive Officer
- Dr. Lin is the founder of AbGenomics. He is the key inventor of more than a dozen worldwide patents. Prior to joining AbGenomics, Dr. Lin was Professor and Director of Graduate Institute of Immunology, College of Medicine, National Taiwan University. Dr. Lin also served as an Associate Editor for Journal of Biomedical Science and a member of the Editorial Board for Int. Immunopharmacology. He received his Diplom, Summa Cum Laude, and Doctor (in Immunology), Magna Cum Laude, degrees from the University of Tübingen in Germany. He has conducted his research works in 3 world renowned institutions: Max Planck Institute for Immunogenetics in Germany, Basel Institute for Immunology in Switzerland, and Immunobiology Division at Howard Hughes Medical Institute at Yale University. In his previous academic research journey he has conducted translational researches and published more than 50 refereed papers.